464 related articles for article (PubMed ID: 17376561)
41. Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold.
Yan LZ; Flora D; Edwards P; Smiley DL; Emmerson PJ; Hsiung HM; Gadski R; Hertel J; Heiman ML; Husain S; O'Brien TP; Kahl SD; Zhang L; Dimarchi RD; Mayer JP
Bioorg Med Chem Lett; 2005 Oct; 15(20):4611-4. PubMed ID: 16105738
[TBL] [Abstract][Full Text] [Related]
42. Discovery and structure-activity relationships of novel alpha-melanocyte-stimulating hormone inhibitors.
Sawyer TK; Staples DJ; Castrucci AM; Hadley ME
Pept Res; 1989; 2(1):140-6. PubMed ID: 2562482
[TBL] [Abstract][Full Text] [Related]
43. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
44. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
[TBL] [Abstract][Full Text] [Related]
45. Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3.
Shimizu N; Dean T; Khatri A; Gardella TJ
J Bone Miner Res; 2004 Dec; 19(12):2078-86. PubMed ID: 15537452
[TBL] [Abstract][Full Text] [Related]
46. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
47. Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors.
Holder JR; Marques FF; Xiang Z; Bauzo RM; Haskell-Luevano C
Eur J Pharmacol; 2003 Feb; 462(1-3):41-52. PubMed ID: 12591094
[TBL] [Abstract][Full Text] [Related]
48. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
[TBL] [Abstract][Full Text] [Related]
49. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
[TBL] [Abstract][Full Text] [Related]
50. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
Frändberg PA; Xu X; Chhajlani V
Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
[TBL] [Abstract][Full Text] [Related]
51. Biostable agonists that match or exceed activity of native insect kinins on recombinant arthropod GPCRs.
Taneja-Bageshwar S; Strey A; Isaac RE; Coast GM; Zubrzak P; Pietrantonio PV; Nachman RJ
Gen Comp Endocrinol; 2009 May; 162(1):122-8. PubMed ID: 18983996
[TBL] [Abstract][Full Text] [Related]
52. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and activity of the melanocortin Xaa-d-Phe-Arg-Trp-NH tetrapeptides with amide bond modifications.
Todorovic A; Holder JR; Scott JW; Haskell-Luevano C
J Pept Res; 2004 Mar; 63(3):270-8. PubMed ID: 15049839
[TBL] [Abstract][Full Text] [Related]
54. Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.
Cheung AW; Danho W; Swistok J; Qi L; Kurylko G; Rowan K; Yeon M; Franco L; Chu XJ; Chen L; Yagaloff K
Bioorg Med Chem Lett; 2003 Jan; 13(1):133-7. PubMed ID: 12467633
[TBL] [Abstract][Full Text] [Related]
55. alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes.
Abdel-Malek ZA; Ruwe A; Kavanagh-Starner R; Kadekaro AL; Swope V; Haskell-Luevano C; Koikov L; Knittel JJ
Pigment Cell Melanoma Res; 2009 Oct; 22(5):635-44. PubMed ID: 19558415
[TBL] [Abstract][Full Text] [Related]
56. γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
Joseph CG; Yao H; Scott JW; Sorensen NB; Marnane RN; Mountjoy KG; Haskell-Luevano C
Peptides; 2010 Dec; 31(12):2304-13. PubMed ID: 20833220
[TBL] [Abstract][Full Text] [Related]
57. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
Getting SJ; Schiöth HB; Perretti M
J Pharmacol Exp Ther; 2003 Aug; 306(2):631-7. PubMed ID: 12750433
[TBL] [Abstract][Full Text] [Related]
58. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
[TBL] [Abstract][Full Text] [Related]
59. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
[TBL] [Abstract][Full Text] [Related]
60. End-capping of the modified melanocortin tetrapeptide (p-Cl)Phe-D-Phe-Arg-Trp-NH2 as a route to hMC4R agonists.
Koikov LN; Ebetino FH; Hayes JC; Cross-Doersen D; Knittel JJ
Bioorg Med Chem Lett; 2004 Oct; 14(19):4839-42. PubMed ID: 15341935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
